RESULTS
In the 2 patients included, translucent hypopigmented areas on gross examination and a translucent white-gray veil and dull yellow globules on dermoscopic examination correlated with the balloon cell melanocytic region demonstrated on histologic studies with hematoxylin-eosin stain. Specifically, dull yellow globules corresponded to the balloon cell melanocytic nests. Both lesions presented with a second, morphologically distinct population of melanocytes, common in balloon cell melanocytic neoplasms. In both cases, a prominent junctional component that consisted of cells demonstrating ample clear-to-granular cytoplasm and a central nucleus were present. Cytologic atypia was minimal to lacking in both cases, and architectural disorder served as a better clue to the diagnosis. Findings of a gene expression profiling test corroborated the diagnosis in both cases.
CONCLUSIONS AND RELEVANCE Balloon cell melanomas may present with characteristic clinical and dermoscopic findings, and a gene expression profiling test may provide additional useful diagnostic information in cases that are difficult to interpret. examination ( Figure 1A) . On dermoscopy, a multicomponent pattern was observed consisting of an asymmetric brown atypical pigment network, dull yellow globules, and a translucent white-gray veil covering a large portion of the lesion ( Figure 1B) .
A shave biopsy of the lesion revealed 2 distinct populations of melanocytes ( Figure 2) . One component consisted of a compound proliferation of small, monomorphous nested melanocytes that matured with descent consistent with a nevus. A separate population of larger melanocytes was observed containing ample clear-to-granular cytoplasm with a central nucleus. Although predominantly nested, subtle atypical architectural features were present, namely, an uneven distribution of nests of melanocytes that varied in size and shape. Immunohistochemical studies confirmed the presence of the BRAF v600E mutation in both components of the lesion.
Although a combined balloon cell nevus (BCN) was considered, a diagnosis of a BCM measuring 0.4 mm arising in association with a compound nevus was established based on the atypical architecture and subtle pleomorphism of the bal- Findings In a case series of 2 patients with balloon cell melanoma, a translucent area on gross examination and semitranslucent white-gray veil and dull yellow globules on dermoscopic examination were features of the balloon cell melanocytic region. Gene expression profiling corroborated that architectural abnormalities provided a better clue than cytologic atypia to the diagnosis of melanoma.
Meaning Balloon cell melanomas may present with characteristic clinical and dermoscopic findings, facilitating recognition, and adjunctive gene expression testing may provide additional diagnostic information in cases of difficult-to-interpret lesions. 
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Myriad Genetics). 1,2 The specimen received a score of 3.4, where scores of 0 to 11.1 are classified as melanoma based on earlier validation studies. A wide local excision of the lesion was performed, and the resection specimen revealed no residual melanoma.
Case 2
A man in his 50s presented with an asymmetrical black macule on the back of his left shoulder measuring 9 × 6 mm ( Figure 1C ). On dermoscopy, asymmetrical peripheral streaks, scalloped borders, and ill-defined black blotches were observed ( Figure 1D ). A shave biopsy of the lesion revealed a broad, asymmetric compound melanocytic neoplasm with 2 distinct populations of melanocytes, one that consisted of ballooned melanocytes and the other of pagetoid melanocytes. Prominent pagetoid spread within the epidermis was observed accompanied by a broad underlying lymphocytic infiltrate ( Figure 3) . Greater than 70% of the lesion consisted of balloon melanocytes with ample clearto-granular cytoplasm and a central nucleus. A diagnosis of BCM measuring 0.4 mm was rendered, which was supported by a score of 5.0 on the gene expression profiling test. 1,2 A wide excision of the lesion revealed no residual melanoma.
Discussion
Ballooning within melanocytes is known to occur in both melanocytic nevi and melanomas. 3, 4 Although small foci of balloon cell change is a relatively common finding in nevi, balloon cell nevi and melanomas, defined as clear or pale cells constituting more than 50% of the neoplasm by volume, are distinctly uncommon. 3, 4 Balloon cell change was once thought to represent a defect in melanosome formation, but electron microscopy has confirmed that this alteration corresponds to progressive vacuolization of melanosomal organelles. 5, 6 Although the clinical appearance of balloon cell melanocytic neoplasms may not be distinctive, characteristic dermoscopic features have been described. [7] [8] [9] [10] [11] [12] Balloon cell nevus may contain white or yellow globules, which correspond to the population of clear cells. 9 The color may reflect the stage of melanosome degeneration, 7 which manifests as clear to variable fine granularity of the cytoplasm observed on histologic study with hematoxylin-eosin. Two other reports of BCM have described white structureless areas on dermoscopy rather than white or yellow globules. 11, 12 Clinically, BCM arising in association with a conventional nevus or superficial spreading melanoma may be more likely to appear pigmented. In case 1, semitranslucent hypopigmentation on gross examination and translucent white-to-gray veil on dermoscopic examination corresponded to the region of the balloon cell melanocytes. To our knowledge, such observations have not been previously reported. Histologically, balloon cell melanocytes are characterized by their large size, round to polygonal shape, and clear, pale, or foamy cytoplasm with a central nucleus. Finely granular and, rarely, coarse and clumped melanin may be observed. Clear cells rarely constitute the entire population of melanocytes in BCN and BCM. Instead, they are usually combined with another distinct population of melanocytes. Because clear cells in BCN and BCM are morphologically similar, distinguishing the two may be challenging. Balloon cell melanomas have been reported to display greater nuclear pleomorphism and a higher Ki67 mitotic index than BCNs. Their architecture may also be more discohesive, often lacking maturation with descent into the dermis. [12] [13] [14] In the largest retrospective study of BCM to date (34 cases), Kao et al 3 reported that more than 70%
of the BCMs had a component of conventional melanocytes. 3 The lesions were described as polypoid and papillomatous and consisting of predominantly dermal nodules abutting the epidermis, some with intraepidermal pagetoid spread overlying the nodules. 3 A mortality rate of 57.5% (19 of 33 patients) was reported (1 patient was lost to follow-up), reflecting the high proportion of melanomas that were thick (>2 mm) at the time of diagnosis, not necessarily that BCMs behave more aggressively when matched for thickness. 3 In thin (<1-mm) balloon cell melanomas, characteristic histologic changes of melanoma, such as significant cytologic atypia, dermal mitoses, and lack of maturation with descent, may not be reliably present, posing a diagnostic challenge for the dermatopathologist. Adjunctive tests, such as comparative genomic hybridization, fluorescence in situ hybridization, and more recently developed gene expression profiling, may provide useful additional diagnostic information.
In both cases described herein, specimens were sent for ancillary testing with a 23-gene expression assay. 
Limitations
Although preliminary data regarding gene expression testing are encouraging, there are several unanswered questions. Of particular concern is the reliability of this method in determining the biological nature of histopathologically ambiguous 
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Clinical Findings and Gene Expression in Balloon Cell Melanoma tumors, the very cases that would prompt ancillary testing. Expert consensus as a criterion standard has limitations, and true validation of this or similar tests will only be possible when a cohort of patients who have undergone biopsy is followed up longitudinally, comparing the predictions with the clinical outcomes. Despite these limitations, the gene expression paradigm may hold promise in the realm of melanoma diagnostics, because quantitative measures of biologically relevant genes in tumorigenesis appear to have the potential to capture differences between benign and malignant neoplasms.
Conclusions
Balloon cell melanomas may present with characteristic clinical and dermoscopic findings. In histologically ambiguous cases, results from an adjunctive gene expression profiling test may provide additional useful diagnostic information. Discovering the molecular underpinnings of BCMs will improve accuracy in establishing diagnosis and prognosis in patients with these rare neoplasms.
